A significant unmet medical need
Emerging AMR in C. difficile is a significant threat to global healthcare systems
CDI is associated with significant economic burden
in annual costs in the US due to CDI
in annual costs in the European Union due to CDI
CDI causes a wide spectrum of disease symptoms that are often debilitating
One of the world's most common infections
Resurging due to waning vaccine protection
Macrolide-resistant B. pertussis is on CDC's AMR "Watch List"
Copyright 2023 Proxi Biotech ApS All Rights Reserved